Veradigm Inc (MDRX)
Veradigm Inc. is a healthcare technology company whose common stock is listed on OTC Markets under the symbol MDRX. The company provides information technology solutions for healthcare providers, payers, and biopharma customers in the United States and internationally. Its portfolio includes practice management software, AI-based patient scheduling, electronic statements and payments, clearinghouse capabilities, revenue cycle and coding services, and electronic health records tools such as ePrescribe with EPCS, Veradigm EHR, and Practice Fusion EHR. Veradigm also serves network partners and life sciences clients with API connectivity, diagnostic ordering and result networks, patient engagement tools, risk adjustment and quality analytics, data exchange and coding solutions, clinical data registries, provider engagement services, care gap alerting, and real-world data and evidence analytics. The company was formerly known as Allscripts Healthcare Solutions, Inc., adopted the Veradigm name in January 2023, and is headquartered in Chicago, Illinois.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-MDRX
|
—
|
—
|
—
|
$6.50
|
35.4% Upside
|
Undervalued
|
Good
|
—
|
—
|
—
|
0.0%
|
July 30, 2026
|
—
|
—
|
—
|
523.2 M
|
—
|
—
|
—
|
—
|
—
|
—
|